PARENT COMPANY ONLY FINANCIAL INFORMATION (Tables)
|
12 Months Ended |
Dec. 31, 2016 |
| PARENT COMPANY ONLY FINANCIAL INFORMATION |
|
| Schedule of condensed balance sheets |
|
|
|
|
|
|
|
|
|
|
Condensed Balance Sheets
|
|
(dollars in thousands)
|
|
|
|
December 31,
|
|
|
|
|
2016
|
|
2015
|
|
|
Assets:
|
|
|
|
|
|
|
|
|
Cash
|
|
$
|
38,803
|
|
$
|
8,318
|
|
|
Investment in common stock of subsidiaries
|
|
|
380,474
|
|
|
325,682
|
|
|
Accrued income taxes receivable
|
|
|
17
|
|
|
2,657
|
|
|
Other assets
|
|
|
2,047
|
|
|
3,644
|
|
|
Total assets
|
|
$
|
421,341
|
|
$
|
340,301
|
|
|
Liabilities:
|
|
|
|
|
|
|
|
|
Subordinated debt
|
|
$
|
54,508
|
|
$
|
61,859
|
|
|
Trust preferred debentures
|
|
|
37,405
|
|
|
37,057
|
|
|
Deferred tax liabilities, net
|
|
|
5,037
|
|
|
5,087
|
|
|
Other liabilities
|
|
|
2,621
|
|
|
3,418
|
|
|
Total liabilities
|
|
|
99,571
|
|
|
107,421
|
|
|
Shareholders’ equity
|
|
|
321,770
|
|
|
232,880
|
|
|
Total liabilities and shareholders’ equity
|
|
$
|
421,341
|
|
$
|
340,301
|
|
|
| Schedule of condensed Statement of income |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statements of Income
|
|
(dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31,
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
|
|
Dividends from subsidiaries
|
|
$
|
—
|
|
$
|
14,500
|
|
$
|
13,600
|
|
|
Other income
|
|
|
428
|
|
|
1,070
|
|
|
—
|
|
|
Interest expense
|
|
|
(5,699)
|
|
|
(4,680)
|
|
|
(1,851)
|
|
|
Other expense
|
|
|
(1,130)
|
|
|
(132)
|
|
|
(60)
|
|
|
(Loss) income before income taxes and equity in undistributed income (loss) of subsidiaries
|
|
|
(6,401)
|
|
|
10,758
|
|
|
11,689
|
|
|
Equity in undistributed income (loss) of subsidiaries
|
|
|
36,256
|
|
|
11,760
|
|
|
(1,403)
|
|
|
Income before income taxes
|
|
|
29,855
|
|
|
22,518
|
|
|
10,286
|
|
|
Income tax benefit
|
|
|
1,687
|
|
|
1,806
|
|
|
530
|
|
|
Net income
|
|
$
|
31,542
|
|
$
|
24,324
|
|
$
|
10,816
|
|
|
| Schedule of condensed cash flows |
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Statements of Cash Flows
|
|
(dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Years ended December 31,
|
|
|
|
|
2016
|
|
2015
|
|
2014
|
|
|
Cash flows from operating activities:
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$
|
31,542
|
|
$
|
24,324
|
|
$
|
10,816
|
|
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
|
|
Equity in undistributed income of subsidiaries
|
|
|
(36,256)
|
|
|
(11,760)
|
|
|
1,403
|
|
|
Amortization of restricted stock awards
|
|
|
555
|
|
|
517
|
|
|
468
|
|
|
Compensation expense for stock option grants
|
|
|
492
|
|
|
413
|
|
|
240
|
|
|
Change in other assets
|
|
|
4,237
|
|
|
(3,559)
|
|
|
576
|
|
|
Change in other liabilities
|
|
|
225
|
|
|
(8,426)
|
|
|
(1,065)
|
|
|
Net cash provided by operating activities
|
|
|
795
|
|
|
1,509
|
|
|
12,438
|
|
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
Net cash acquired in acquisition
|
|
|
—
|
|
|
(20,053)
|
|
|
1,500
|
|
|
Capital injection to subsidiaries
|
|
|
(25,250)
|
|
|
(30,000)
|
|
|
—
|
|
|
Net cash (used in) provided by investing activities
|
|
|
(25,250)
|
|
|
(50,053)
|
|
|
1,500
|
|
|
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
Payment made on subordinated debt
|
|
|
(8,000)
|
|
|
—
|
|
|
—
|
|
|
Proceeds from issuance of subordinated debt, net of issuance costs
|
|
|
—
|
|
|
55,325
|
|
|
—
|
|
|
Proceeds from other borrowings
|
|
|
—
|
|
|
—
|
|
|
14,000
|
|
|
Payments made on other borrowings
|
|
|
—
|
|
|
(14,000)
|
|
|
(15,938)
|
|
|
Cash dividends paid on common stock
|
|
|
(9,853)
|
|
|
(7,692)
|
|
|
(3,512)
|
|
|
Cash dividends paid on preferred stock
|
|
|
—
|
|
|
—
|
|
|
(4,254)
|
|
|
Proceeds from issuance of common stock in initial public offering, net of issuance costs
|
|
|
71,475
|
|
|
—
|
|
|
—
|
|
|
Proceeds from issuance of common stock under employee benefit plans
|
|
|
1,318
|
|
|
470
|
|
|
215
|
|
|
Net cash provided by (used in) financing activities
|
|
|
54,940
|
|
|
34,103
|
|
|
(9,489)
|
|
|
Net increase (decrease) in cash
|
|
|
30,485
|
|
|
(14,441)
|
|
|
4,449
|
|
|
Cash:
|
|
|
|
|
|
|
|
|
|
|
|
Beginning of year
|
|
|
8,318
|
|
|
22,759
|
|
|
18,310
|
|
|
End of year
|
|
$
|
38,803
|
|
$
|
8,318
|
|
$
|
22,759
|
|
|
Supplemental disclosures of noncash investing and financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
Conversion of Series C preferred stock into common stock
|
|
$
|
—
|
|
$
|
—
|
|
$
|
23,600
|
|
|
Conversion of Series D preferred stock into common stock
|
|
|
—
|
|
|
—
|
|
|
22,470
|
|
|
Conversion of Series E preferred stock into common stock
|
|
|
—
|
|
|
—
|
|
|
6,300
|
|
|
Conversion of Series F preferred stock into common stock
|
|
|
—
|
|
|
—
|
|
|
5,000
|
|
|
Issuance of common stock for preferred dividends
|
|
|
—
|
|
|
—
|
|
|
2,903
|
|
|
Cash portion of merger consideration accrued for at year-end
|
|
|
—
|
|
|
—
|
|
|
20,053
|
|
|
Issuance of common stock for private placement
|
|
|
—
|
|
|
—
|
|
|
16,156
|
|
|